PTD-939

N/A

Report date: 2025/04/01 15:33:49
NME

Base Information

Drug NamePTD-939
Drug Alias NamePTD-939
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionG protein-coupled receptor 17 antagonists
TargetsG protein-coupled receptor 17
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPheno Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPheno Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A